Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1996-01-18
1999-10-05
Gitomer, Ralph
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
A61K 3578
Patent
active
059619805
ABSTRACT:
A composition containing a Bowman Birk Inhibitor and a pharmaceutically acceptable carrier are provided for treatment of genitourinary tract diseases relating to smooth muscle contraction leading to urinary symptoms and male sexual dysfunction or atypical prostate cells. Methods of using these compositions in treatment of these diseases are also provided.
REFERENCES:
patent: 4793996 (1988-12-01), Kennedy et al.
patent: 5217717 (1993-06-01), Kennedy et al.
patent: 5505946 (1996-04-01), Kennedy et al.
patent: 5550042 (1996-08-01), Sambrook et al.
Baturay et al., "Pyrene Acts as a Cocarcinogen with the Carcinogens Benzo Malignant Transformation in Cultured Mouse Fibroblasts; Soybean Extract Containing the Bowman-Birk Inhibitor Acts as an Antocarcinogen".
Birk et al., "Separation of a Tribolium-protease inhibitor from soybeans on a calcium phosphate column", Biochim. Biophys. Acta 1963, 67,326.
Bowman,D.E., "Differentiation of Soy Bean Antitryptic Factors", Proc. Soc. Exptl. Med. 1946, 63, 547.
Evans et al., "Protection against Metastasis of Radiation-Induced Thymic Lymphosarcoma and Weight Loss in C57B1/6NCr1BR Mice by an Autoclave-Resistant Factor Present in Soybeans", Radiat. Res. 1992,132, 259-262.
Frenkel et al., "Chymotrypsin-specific protease inhibitors decrease H.sup.2 O.sup.2 formation by activated human polymorphonuclear leukocytes",Carcinogenesis 1987, 8(9), 1207-1212.
Gibas et al., "A High-Resolution Study of Chromosome Changes in a Human Prostatic Carcinoma Cell Line (LNCaP)", Cancer Genet. Cytogen. 1984, 11, 399-404.
Horoszewicz et al., "LNCaP Model of Human Prostatic Carcinoma", Cancer Res. 1983, 43, 1809-1818.
Kaighn et al., Establishment and Characterization of a Human Prostatic Carcinoma Cell Line (PC-3), Invest. Urol. 1979, 17, 16-23.
Kennedy, "Cancer Prevention by Protease Inhibitors", Prevent. Med. 1993, 22, 796-811, pp. 797.
Kennedy, "The Evidence for Soybean Products as Cancer Preventive Agents", J. Nutr. 1995, 125, 733S-743S.
Messadi et al., "Inhibition of Oral Carcinogenesis by a Protease Inhibitor", JNCI 1986, 76, 447-452.
Muschel et al., "Induction of Apoptosis at Different Oxygen Tensions: Evidence That Oxygen Radicals Do Not Mediate Apoptotic Signaling", Cancer Res. 1995, 55, 995-998.
Ohnuki et al., "Chromosomal Analysis of Human Prostatic Adenocarcinoma Cell Lines", Cancer Res. 1989, 40, 524-534.
Perlmann et al., "Proteolytic Enzymes", Methods in Enzymology 1970, 19, 860-861.
Samid et al., "Selective Growth Arrest and Phenotypic Reversion of Prostate Cancer Cells In Vitro by Nontoxic Pharmacological Concentrations of Phenylacetate", J. Clin Invest. 1993, 91, 2288-2295.
St. Clair et al., "Suppression of Dimethylhydrazine-induced Carcinogenesis in Mice by Dietary Addition of the Bowman-Birk Protease Inhibitor", Cancer Res. 1990, 50, 580-586.
von Hofe et al., "Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birm protease inhibitor", Carcinogenesis 1991, 12, 2147-2150.
Vindelov and Christensen, "A Review of Techniques and Results Obtained in One Laboratory by an Integrated System of Methods Designed for Routine Clinical Flow Cytometric DNA Analysis", Cytometry 1990, 11, 753-770.
Ware et al., "Spontaneous Metastasis of Cells of the Human Prostate Carcinoma Cell Line PC-3 in Athymic Nude Mice", J. Urol. 1982, 128, 1064-1067.
Weed et al., "Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor", Carcinogenesis 1985, 6, 1239-1241.
Yavelow et al., "Bowman-Birk Soybean Protease Inhibitor as an Anticarcinogen", Cancer Res. 1983, 43, 2454-2459.
Yavelow et al., "Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro", Proc. Natl. Acad. Sci. USA 1985, 82, 5395-5399.
Kennedy A., The Evidence for Soybean Products as Cancer Prventive Agents, J Nutr 125:733S-743S, 1995.
Clark Larry
Kennedy Ann R.
Gitomer Ralph
The Trustees of the University of Pennsylvania
LandOfFree
Bowman-birk inhibitor compositions and methods for the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bowman-birk inhibitor compositions and methods for the treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bowman-birk inhibitor compositions and methods for the treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168405